BMDL10
- Guideline or reference source
- ICHM7 Assessment and control of dna reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk
- Definition
- The lower 95% confidence interval of a Benchmark-dose representing a 10% response (e.g., tumor response upon lifetime exposure), i.e., the lower 95% confidence interval of a BMD10. BMD10 is the Benchmark-dose (BMD) associated with a 10% response adjusted for background
- Related Term
- dose
Send comments to info@celegence.com Please read disclaimer before using Qsauri.